Median Technologies SA (EPA:ALMDT)
France
· Delayed Price · Currency is EUR 3.090
-0.070 (-2.22%)
Dec 5, 2025, 5:35 PM CET
Median Technologies Revenue
Median Technologies had revenue of 11.36M EUR in the half year ending June 30, 2025, a decrease of -0.30%. This brings the company's revenue in the last twelve months to 23.38M, up 4.76% year-over-year. In the year 2024, Median Technologies had annual revenue of 22.96M with 0.79% growth.
Revenue (ttm)
23.38M
Revenue Growth
+4.76%
P/S Ratio
4.85
Revenue / Employee
110.82K
Employees
225
Market Cap
113.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22.96M | 180.00K | 0.79% |
| Dec 31, 2023 | 22.78M | -1.17M | -4.87% |
| Dec 31, 2022 | 23.95M | 3.38M | 16.45% |
| Dec 31, 2021 | 20.56M | 6.97M | 51.30% |
| Dec 31, 2020 | 13.59M | 4.56M | 50.48% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sanofi | 45.93B |
| Sartorius Stedim Biotech | 2.95B |
| bioMérieux | 4.12B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 6.02M |
| Virbac | 1.43B |